{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T09:02:32Z","timestamp":1789981352336,"version":"4.0.1"},"reference-count":534,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["DA05312"],"award-info":[{"award-number":["DA05312"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["HL73085"],"award-info":[{"award-number":["HL73085"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["RR021954"],"award-info":[{"award-number":["RR021954"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["UL1TR000117"],"award-info":[{"award-number":["UL1TR000117"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["UL1TR001998"],"award-info":[{"award-number":["UL1TR001998"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["715489B"],"award-info":[{"award-number":["715489B"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.pharmthera.2016.10.015","type":"journal-article","created":{"date-parts":[[2016,10,21]],"date-time":"2016-10-21T02:45:49Z","timestamp":1477017949000},"page":"116-147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":159,"special_numbering":"C","title":["Obesity: Current and potential pharmacotherapeutics and targets"],"prefix":"10.1016","volume":"170","author":[{"given":"Vidya","family":"Narayanaswami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda P.","family":"Dwoskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2016.10.015_bb0005","article-title":"Mechanism underlying the weight loss and complications of Roux-en-Y gastric bypass. Review","author":"Abdeen","year":"2015","journal-title":"Obes Surg"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0010","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1172\/JCI29867","article-title":"Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite","volume":"116","author":"Abizaid","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0015","author":"ADIPEX-P\u00ae Prescribing Information"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0020","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0091-3057(95)00128-J","article-title":"Reward and reinforcement produced by drinking sucrose: Two processes that may depend on different neurotransmitters","volume":"52","author":"Agmo","year":"1995","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0025","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/hmg\/ddi455","article-title":"A PYY Q62P variant linked to human obesity","volume":"15","author":"Ahituv","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0030","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.pbb.2010.10.004","article-title":"Circulating leptin levels are associated with increased craving to smoke in abstinent smokers","volume":"97","author":"al'Absi","year":"2011","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0035","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1210\/en.2011-1443","article-title":"GLP-1 neurons in the nucleus of the solitary tract project directly to the ventral tegmental area and nucleus accumbens to control for food intake","volume":"153","author":"Alhadeff","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0040","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/oby.2011.330","article-title":"Controlled-release phentermine\/topiramate in severely obese adults: A randomized controlled trial (EQUIP)","volume":"20","author":"Allison","year":"2012","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0045","series-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-5","first-page":"350","author":"American Psychiatric Association","year":"2013"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0050","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1517\/14656566.8.11.1733","article-title":"Orlistat for the management of overweight individuals and obesity: A review of potential for the 60-mg, over-the-counter dosage","volume":"8","author":"Anderson","year":"2007","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0055","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.neuroscience.2006.08.064","article-title":"Restricted feeding schedules phase shift daily rhythms of c-Fos and protein Per1 immunoreactivity in corticolimbic regions in rats","volume":"144","author":"Angeles-Castellanos","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0060","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/oby.20309","article-title":"A randomized, phase 3 trial of naltrexone SR\/bupropion SR on weight and obesity-related risk factors (COR-II)","volume":"21","author":"Apovian","year":"2013","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0065","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/bbrc.1999.0255","article-title":"Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity","volume":"257","author":"Arita","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0070","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11695-012-0802-1","article-title":"A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass","volume":"23","author":"Arterburn","year":"2013","journal-title":"Obes Surg"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0075","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1210\/endo.142.10.8416","article-title":"Absence of cocaine- and amphetamine-regulated transcript results in obesity in mice fed a high caloric diet","volume":"142","author":"Asnicar","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0080","doi-asserted-by":"crossref","first-page":"R1407","DOI":"10.1152\/ajpregu.00664.2005","article-title":"Postprandial increase of oleoylethanolamide mobilization in small intestine of the Burmese python (Python molurus)","volume":"290","author":"Astarita","year":"2006","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0085","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1016\/S0140-6736(08)61525-1","article-title":"Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: A randomized, double-blind, placebo-controlled trial","volume":"372","author":"Astrup","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0090","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/oby.2008.56","article-title":"Weight loss produced by tesofensine in patients with Parkinson's or Alzheimer's disease","volume":"16","author":"Astrup","year":"2008","journal-title":"Obesity (Silver Spring)"},{"issue":"iii-iv","key":"10.1016\/j.pharmthera.2016.10.015_bb0095","first-page":"1","article-title":"Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement","volume":"8","author":"Avenell","year":"2004","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0100","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1038\/npp.2010.16","article-title":"Tesofensine, a novel triple monoamine reuptake inhibitor, induces appetite suppression by indirect stimulation of alpha1 adrenoceptor and dopamine D1 receptor pathways in the diet-induced obese rat","volume":"35","author":"Axel","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0105","doi-asserted-by":"crossref","first-page":"R167","DOI":"10.1152\/ajpregu.00067.2014","article-title":"Vagal afferents are not necessary for the satiety effect of the gut lipid messenger oleoylethanolamide","volume":"307","author":"Azari","year":"2014","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0110","doi-asserted-by":"crossref","first-page":"15718","DOI":"10.1073\/pnas.0407076101","article-title":"The gut microbiota as an environmental factor that regulates fat storage","volume":"101","author":"Backhed","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0115","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1053\/j.gastro.2004.04.063","article-title":"Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure","volume":"127","author":"Baggio","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0120","doi-asserted-by":"crossref","first-page":"R1048","DOI":"10.1152\/ajpregu.90701.2008","article-title":"A tasty morsel: the role of the dorsal vagal complex in the regulation of food intake and swallowing. Focus on \u201cBDNF\/TrkB signaling interacts with GABAergic system to inhibit rhythmic swallowing in the rat,\u201d by Bariohay et al","volume":"295","author":"Bailey","year":"2008","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0125","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3389\/fphys.2014.00420","article-title":"Release of GLP-1 and PYY in response to the activation of G protein-coupled bile acid receptor TGR5 is mediated by Epac\/PLC-epsilon pathway and modulated by endogenous H2S","volume":"5","author":"Bala","year":"2014","journal-title":"Front Physiol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0130","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1042\/cs0890375","article-title":"Cholecystokinin is a satiety hormone in humans at physiological post-prandial plasma concentrations","volume":"89","author":"Ballinger","year":"1995","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0135","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1749-6632.2003.tb03176.x","article-title":"The gut hormone peptide YY regulates appetite","volume":"994","author":"Batterham","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0140","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/oby.20663","article-title":"Canagliflozin: effects in overweight and obese subjects without diabetes mellitus","volume":"22","author":"Bays","year":"2014","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0145","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/oby.2003.78","article-title":"Predictors of weight loss in adults with topiramate-treated epilepsy","volume":"11","author":"Ben-Menachem","year":"2003","journal-title":"Obes Res"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0150","doi-asserted-by":"crossref","first-page":"9048","DOI":"10.1523\/JNEUROSCI.22-20-09048.2002","article-title":"The catabolic action of insulin in the brain is mediated by melanocortins","volume":"22","author":"Benoit","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0155","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/90992","article-title":"The adipocyte-secreted protein Acrp30 enhances hepatic insulin action","volume":"7","author":"Berg","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0160","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0149-7634(99)00072-X","article-title":"Measuring hedonic impact in animals and infants: microstructure of affective taste reactivity patterns","volume":"24","author":"Berridge","year":"2000","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0165","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0165-0173(98)00019-8","article-title":"What is the role of dopamine in reward: Hedonic impact, reward learning, or incentive salience?","volume":"28","author":"Berridge","year":"1998","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0170","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nrendo.2013.64","article-title":"The GH\/IGF-1 axis in obesity: Pathophysiology and therapeutic considerations","volume":"9","author":"Berryman","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0175","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0149-7634(02)00014-3","article-title":"Multiple neural systems controlling food intake and body weight","volume":"26","author":"Berthoud","year":"2002","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0180","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.conb.2011.09.004","article-title":"Metabolic and hedonic drives in the neural control of appetite: Who is the boss?","volume":"21","author":"Berthoud","year":"2011","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0185","doi-asserted-by":"crossref","first-page":"R254","DOI":"10.1152\/ajpregu.2001.281.1.R254","article-title":"A role for NPY overexpression in the dorsomedial hypothalamus in hyperphagia and obesity of OLETF rats","volume":"281","author":"Bi","year":"2001","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0190","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1054\/npep.2002.0895","article-title":"Actions of CCK in the controls of food intake and body weight: lessons from the CCK-A receptor deficient OLETF rat","volume":"36","author":"Bi","year":"2002","journal-title":"Neuropeptides"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2014.04.004","article-title":"Naltrexone\/bupropion for obesity: An investigational combination pharmacotherapy for weight loss","volume":"84","author":"Billes","year":"2014","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0200","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/1479164109346359","article-title":"Lifestyle risk factors for atherosclerosis in adults with type 1 diabetes","volume":"6","author":"Bishop","year":"2009","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0205","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1210\/endo-123-6-2782","article-title":"Oxyntomodulin and glicentin: Brain-gut peptides in the rat","volume":"123","author":"Blache","year":"1988","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(99)02477-4","article-title":"Brain regions where cholecystokinin suppresses feeding in rats","volume":"860","author":"Blevins","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0215","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.2337\/diacare.25.11.2088","article-title":"Obesity, hypertension, and insulin resistance","volume":"25","author":"Bloomgarden","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0220","first-page":"15","article-title":"Is there a role for serotonin (5-hydroxytryptamine) in feeding?","volume":"1","author":"Blundell","year":"1977","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0225","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0165-6147(91)90532-W","article-title":"Pharmacological approaches to appetite suppression","volume":"12","author":"Blundell","year":"1991","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0230","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.cell.2006.06.049","article-title":"Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network","volume":"126","author":"Bookout","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0235","doi-asserted-by":"crossref","first-page":"11215","DOI":"10.1523\/JNEUROSCI.6096-08.2009","article-title":"Orexin A\/hypocretin-1 selectively promotes motivation for positive reinforcers","volume":"29","author":"Borgland","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0240","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1038\/oby.2010.57","article-title":"Food-related odor probes of brain reward circuits during hunger: A pilot FMRI study","volume":"18","author":"Bragulat","year":"2010","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0245","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/978-1-4899-1236-7_11","article-title":"Insulin structure and stability","volume":"5","author":"Brange","year":"1993","journal-title":"Pharm Biotechnol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0250","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/oby.2003.102","article-title":"A 6-month randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesity","volume":"11","author":"Bray","year":"2003","journal-title":"Obes Res"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0255","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1210\/jc.2009-0438","article-title":"Peak growth hormone-releasing hormone-arginine-stimulated growth hormone is inversely associated with intramyocellular and intrahepatic lipid content in premenopausal women with obesity","volume":"94","author":"Bredella","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0260","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/(SICI)1098-2396(199605)23:1<39::AID-SYN5>3.0.CO;2-I","article-title":"Noradrenergic mechanisms in stress and anxiety: II. Clinical studies","volume":"23","author":"Bremner","year":"1996","journal-title":"Synapse"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0265","doi-asserted-by":"crossref","first-page":"15043","DOI":"10.1073\/pnas.95.25.15043","article-title":"The neuropeptide Y\/agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice","volume":"95","author":"Broberger","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0270","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1177\/106002809603000517","article-title":"Pathophysiology and management of the serotonin syndrome","volume":"30","author":"Brown","year":"1996","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0275","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.bbr.2011.01.020","article-title":"Effects of insulin and leptin in the ventral tegmental area and arcuate hypothalamic nucleus on food intake and brain reward function in female rats","volume":"219","author":"Bruijnzeel","year":"2011","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0280","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1210\/endo.137.7.8770921","article-title":"Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor","volume":"137","author":"Bullock","year":"1996","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0285","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1210\/jc.2003-031267","article-title":"Postprandial suppression of plasma ghrelin level is proportional to ingested caloric load but does not predict intermeal interval in humans","volume":"89","author":"Callahan","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0290","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.neuropharm.2013.04.030","article-title":"The use of the reinstatement model to study relapse to palatable food seeking during dieting","volume":"76 Pt B","author":"Calu","year":"2014","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.pharmthera.2016.10.015_bb0295","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1053\/j.gastro.2014.09.016","article-title":"Peripheral mechanisms in appetite regulation","volume":"148","author":"Camilleri","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0300","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1055\/s-2007-979867","article-title":"The OB protein (leptin) pathway \u2014 A link between adipose tissue mass and central neural networks","volume":"28","author":"Campfield","year":"1996","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0305","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1046\/j.1471-4159.2002.00892.x","article-title":"PI 3-kinase regulation of dopamine uptake","volume":"81","author":"Carvelli","year":"2002","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0310","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00213-012-2902-y","article-title":"Role of orexin\/hypocretin in conditioned sucrose-seeking in rats","volume":"226","author":"Cason","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0315","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.physbeh.2010.03.009","article-title":"Role of orexin\/hypocretin in reward-seeking and addiction: Implications for obesity","volume":"100","author":"Cason","year":"2010","journal-title":"Physiol Behav"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0320","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0304-3940(94)90096-5","article-title":"Direct in vivo evidence that D2 dopamine receptors can modulate dopamine uptake","volume":"176","author":"Cass","year":"1994","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0325","author":"CDC Report"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0330","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s002130050518","article-title":"Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats","volume":"135","author":"Chaperon","year":"1998","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0335","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.2174\/138161212799504858","article-title":"Non-systemic drugs: A critical review","volume":"18","author":"Charmot","year":"2012","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0340","doi-asserted-by":"crossref","first-page":"R1695","DOI":"10.1152\/ajpregu.00870.2004","article-title":"Intravenous infusion of glucagon-like peptide-1 potently inhibits food intake, sham feeding, and gastric emptying in rats","volume":"288","author":"Chelikani","year":"2005","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0345","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/79254","article-title":"Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass","volume":"26","author":"Chen","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0350","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1210\/jc.2014-4024","article-title":"RM-493, a melanocortin-4 receptor (MC4R) agonist, increases resting energy expenditure in obese individuals","volume":"100","author":"Chen","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0355","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1124\/mol.52.6.1164","article-title":"Expression cloning and receptor pharmacology of human calcitonin receptors from MCF-7 cells and their relationship to amylin receptors","volume":"52","author":"Chen","year":"1997","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0360","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1210\/endo.143.7.8903","article-title":"Targeted disruption of the melanin-concentrating hormone receptor-1 results in hyperphagia and resistance to diet-induced obesity","volume":"143","author":"Chen","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0365","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1365-2265.2009.03586.x","article-title":"Cigarette smoking is an independent risk factor for type 2 diabetes: A four-year community-based prospective study","volume":"71","author":"Cho","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0031-9384(02)00784-9","article-title":"TRH decreases food intake and increases water intake and body temperature in rats","volume":"77","author":"Choi","year":"2002","journal-title":"Physiol Behav"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0375","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/S0140-6736(07)61721-8","article-title":"Efficacy and safety of the weight-loss drug rimonabant: A meta-analysis of randomized trials","volume":"370","author":"Christensen","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0380","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1124\/mol.56.1.235","article-title":"Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product","volume":"56","author":"Christopoulos","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0385","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2337\/diacare.19.6.667","article-title":"Bromocriptine (Ergoset) reduces body weight and improves glucose tolerance in obese subjects","volume":"19","author":"Cincotta","year":"1996","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0390","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1210\/jcem.86.8.7731","article-title":"Abdominal visceral fat and fasting insulin are important predictors of 24-hour GH release independent of age, gender, and other physiological factors","volume":"86","author":"Clasey","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0395","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/BF02246345","article-title":"Naloxone effects on sucrose-motivated behavior","volume":"126","author":"Cleary","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0400","doi-asserted-by":"crossref","first-page":"288","DOI":"10.15252\/emmm.201404508","article-title":"Dual melanocortin-4 receptor and GLP-1 receptor agonism amplifies metabolic benefits in diet-induced obese mice","volume":"7","author":"Clemmensen","year":"2015","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0405","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1097\/00001756-200111160-00035","article-title":"Excessive sugar intake alters binding to dopamine and mu-opioid receptors in the brain","volume":"12","author":"Colantuoni","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0410","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/oxfordjournals.aje.a115686","article-title":"Weight as a risk factor for clinical diabetes in women","volume":"132","author":"Colditz","year":"1990","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0415","doi-asserted-by":"crossref","first-page":"16143","DOI":"10.1038\/srep16143","article-title":"Orexin\/hypocretin-1 receptor antagonism selectively reduces cue-induced feeding in sated rats and recruits medial prefrontal cortex and thalamus","volume":"5","author":"Cole","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0420","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMp1211277","article-title":"The FDA's assessment of two drugs for chronic weight management","volume":"367","author":"Colman","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0425","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.mam.2012.10.005","article-title":"Obesity pharmacotherapy: What is next?","volume":"34","author":"Colon-Gonzalez","year":"2013","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0430","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1210\/en.2005-1649","article-title":"Requirement of cannabinoid receptor type 1 for the basal modulation of hypothalamic-pituitary-adrenal axis function","volume":"148","author":"Cota","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0435","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/sj.npp.1301430","article-title":"Opioid-dependent anticipatory negative contrast and binge-like eating in rats with limited access to highly preferred food","volume":"33","author":"Cottone","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0440","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/ndt\/gfl684","article-title":"Rapidly progressive renal failure associated with successful pharmacotherapy for obesity","volume":"22","author":"Courtney","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0445","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0896-6273(00)80829-6","article-title":"Integration of NPY, AGRP, and melanocortin signals in the hypothalamic paraventricular nucleus: evidence of a cellular basis for the adipostat","volume":"24","author":"Cowley","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0450","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/35078085","article-title":"Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus","volume":"411","author":"Cowley","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0455","doi-asserted-by":"crossref","first-page":"E2229","DOI":"10.1073\/pnas.1219485110","article-title":"Obesity-driven synaptic remodeling affects endocannabinoid control of orexinergic neurons","volume":"110","author":"Cristino","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0460","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1210\/en.2011-1499","article-title":"Minireview: Glucagon in the pathogenesis of hypoglycemia and hyperglycemia in diabetes","volume":"153","author":"Cryer","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0465","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/MOL.0b013e32836139df","article-title":"Microsomal transfer protein inhibition in humans","volume":"24","author":"Cuchel","year":"2013","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0470","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.physbeh.2006.05.022","article-title":"Ghrelin and the short- and long-term regulation of appetite and body weight","volume":"89","author":"Cummings","year":"2006","journal-title":"Physiol Behav"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0475","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.2337\/diabetes.50.8.1714","article-title":"A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans","volume":"50","author":"Cummings","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0480","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/1801124a0","article-title":"Calorigenic action of glucagon","volume":"180","author":"Davidson","year":"1957","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0485","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0014-2999(92)90645-K","article-title":"Effects on ingestive behavior in rats of the alpha 1-adrenoceptor agonist cirazoline","volume":"210","author":"Davies","year":"1992","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0490","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.biopsych.2010.08.028","article-title":"Leptin regulates energy balance and motivation through action at distinct neural circuits","volume":"69","author":"Davis","year":"2011","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0495","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000170586","article-title":"Bromocriptine administration reduces hyperphagia and adiposity and differentially affects dopamine D2 receptor and transporter binding in leptin-receptor-deficient Zucker rats and rats with diet-induced obesity","volume":"89","author":"Davis","year":"2009","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0500","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1037\/a0013111","article-title":"Exposure to elevated levels of dietary fat attenuates psychostimulant reward and mesolimbic dopamine turnover in the rat","volume":"122","author":"Davis","year":"2008","journal-title":"Behav Neurosci"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0505","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1073\/pnas.95.1.322","article-title":"The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity","volume":"95","author":"de Lecea","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0510","series-title":"Advancing from the ventral striatum to the extended amygdala: Implications for neuropsychiatry and drug abuse","first-page":"1","article-title":"The concepts of the ventral striatopallidal system and extended amygdala","author":"De Olmos","year":"1999"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0515","doi-asserted-by":"crossref","first-page":"655","DOI":"10.2174\/138161208783877820","article-title":"Are carbonic anhydrase inhibitors suitable for obtaining antiobesity drugs?","volume":"14","author":"De Simone","year":"2008","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0520","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/S0196-9781(01)00450-8","article-title":"The effect of cholecystokinin in controlling appetite and food intake in humans","volume":"22","author":"Degen","year":"2001","journal-title":"Peptides"},{"issue":"Suppl. 2","key":"10.1016\/j.pharmthera.2016.10.015_bb0525","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1038\/ijo.2009.67","article-title":"The endocannabinoid system as a link between homoeostatic and hedonic pathways involved in energy balance regulation","volume":"33","author":"Di Marzo","year":"2009","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0530","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.neuroscience.2010.10.005","article-title":"Blockade of central nicotine acetylcholine receptor signaling attenuate ghrelin-induced food intake in rodents","volume":"171","author":"Dickson","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0535","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1523\/JNEUROSCI.6326-11.2012","article-title":"The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptors","volume":"32","author":"Dickson","year":"2012","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0540","doi-asserted-by":"crossref","first-page":"12904","DOI":"10.1073\/pnas.1104675108","article-title":"Endocannabinoid signal in the gut controls dietary fat intake","volume":"108","author":"DiPatrizio","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0545","doi-asserted-by":"crossref","first-page":"R805","DOI":"10.1152\/ajpregu.00239.2015","article-title":"Fasting stimulates 2-AG biosynthesis in the small intestine: Role of cholinergic pathways","volume":"309","author":"DiPatrizio","year":"2015","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0550","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1096\/fj.13-227587","article-title":"Endocannabinoid signaling in the gut mediates preference for dietary unsaturated fats","volume":"27","author":"DiPatrizio","year":"2013","journal-title":"FASEB J"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0555","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1172\/JCI76302","article-title":"Intestinal lipid-derived signals that sense dietary fat","volume":"125","author":"DiPatrizio","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0560","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/sj.ijo.0803001","article-title":"Ghrelin increases food intake in obese as well as lean subjects","volume":"29","author":"Druce","year":"2005","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0565","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1210\/en.2006-0494","article-title":"Enhancing the action of incretin hormones: A new whey forward?","volume":"147","author":"Drucker","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0570","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1172\/JCI30076","article-title":"The role of gut hormones in glucose homeostasis","volume":"117","author":"Drucker","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0575","doi-asserted-by":"crossref","first-page":"13475","DOI":"10.1016\/S0021-9258(18)68261-4","article-title":"Glucagon gene expression in vertebrate brain","volume":"263","author":"Drucker","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0580","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1152\/physrev.00014.2005","article-title":"Cholecystokinin and gastrin receptors","volume":"86","author":"Dufresne","year":"2006","journal-title":"Physiol Rev"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0585","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0022-3565(25)24459-7","article-title":"Characterization of neuropeptide Y binding sites in rat brain membrane preparations using [125I][Leu31,Pro34]peptide YY and [125I]peptide YY3-36 as selective Y1 and Y2 radioligands","volume":"272","author":"Dumont","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0590","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2337\/dc11-0931","article-title":"Short-term exenatide treatment leads to significant weight loss in a subset of obese women without diabetes","volume":"35","author":"Dushay","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0595","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1527-3458.2006.00178.x","article-title":"Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent","volume":"12","author":"Dwoskin","year":"2006","journal-title":"CNS Drug Rev"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0600","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.2337\/diabetes.48.10.2028","article-title":"Involvement of agouti-related protein, an endogenous antagonist of hypothalamic melanocortin receptor, in leptin action","volume":"48","author":"Ebihara","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0605","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(05)66378-7","article-title":"The metabolic syndrome","volume":"365","author":"Eckel","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0610","first-page":"27","article-title":"TGR5 ligands as potential therapeutics in inflammatory diseases","volume":"6","author":"Eggink","year":"2014","journal-title":"Int J Interferon Cytokine Mediator Res"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0615","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/edrv-1-1-1","article-title":"Structure and biosynthesis of pro-adrenocorticotropin\/endorphin and related peptides","volume":"1","author":"Eipper","year":"1980","journal-title":"Endocr Rev"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0620","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0896-6273(00)80656-X","article-title":"Leptin activates hypothalamic CART neurons projecting to the spinal cord","volume":"21","author":"Elias","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0625","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1210\/jc.2008-0115","article-title":"Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in overweight women with polycystic ovary syndrome","volume":"93","author":"Elkind-Hirsch","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0630","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/2164","article-title":"Unraveling the central nervous system pathways underlying responses to leptin","volume":"1","author":"Elmquist","year":"1998","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0635","author":"European Medicines Agency"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0640","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nm1025","article-title":"PPARs and the complex journey to obesity","volume":"10","author":"Evans","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0645","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1037\/0735-7036.101.4.395","article-title":"Studies of instrumental behavior with sexual reinforcement in male rats (Rattus norvegicus): I. Control by brief visual stimuli paired with a receptive female","volume":"101","author":"Everitt","year":"1987","journal-title":"J Comp Psychol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0650","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/nn1579","article-title":"Neural systems of reinforcement for drug addiction: from actions to habits to compulsion","volume":"8","author":"Everitt","year":"2005","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0655","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nm.3760","article-title":"Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance","volume":"21","author":"Fang","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0660","author":"FDA"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0665","author":"FDA draft guidance"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0670","author":"FDA draft guidance"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0675","author":"FDA"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0680","author":"FDA drug safety communication"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0685","author":"FDA"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0690","author":"FDA"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0695","author":"FDA"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0700","author":"FDA"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0705","doi-asserted-by":"crossref","first-page":"7001","DOI":"10.1073\/pnas.94.13.7001","article-title":"Anatomic localization of alternatively spliced leptin receptors (Ob-R) in mouse brain and other tissues","volume":"94","author":"Fei","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0710","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1523\/JNEUROSCI.20-04-01550.2000","volume":"20","author":"Fekete","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0715","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1523-1755.2004.00790.x","article-title":"Fat malabsorption induced by gastrointestinal lipase inhibitor leads to an increase in urinary oxalate excretion","volume":"66","author":"Ferraz","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0720","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1037\/0735-7044.118.3.479","article-title":"Intraventricular insulin and leptin reverse place preference conditioned with high-fat diet in rats","volume":"118","author":"Figlewicz","year":"2004","journal-title":"Behav Neurosci"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0725","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.physbeh.2006.07.023","article-title":"Intraventricular insulin and leptin decrease sucrose self-administration in rats","volume":"89","author":"Figlewicz","year":"2006","journal-title":"Physiol Behav"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0730","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0006-8993(02)04087-8","article-title":"Expression of receptors for insulin and leptin in the ventral tegmental area\/substantia nigra (VTA\/SN) of the rat","volume":"964","author":"Figlewicz","year":"2003","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0735","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0031-9384(01)00486-3","article-title":"Leptin reverses sucrose-conditioned place preference in food-restricted rats","volume":"73","author":"Figlewicz","year":"2001","journal-title":"Physiol Behav"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0740","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0006-8993(94)91698-5","article-title":"Intraventricular insulin increases dopamine transporter mRNA in rat VTA\/substantia nigra","volume":"644","author":"Figlewicz","year":"1994","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0745","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1345\/aph.1R779","article-title":"New obesity agents: Lorcaserin and phentermine\/topiramate","volume":"47","author":"Fleming","year":"2013","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0750","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/sj.ijo.0801627","article-title":"The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity","volume":"25","author":"Flint","year":"2001","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0755","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1152\/physrev.1983.63.3.844","article-title":"Nucleus locus ceruleus: New evidence of anatomical and physiological specificity","volume":"63","author":"Foote","year":"1983","journal-title":"Physiol Rev"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0760","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/0092-8674(95)90530-8","article-title":"Identification of a nuclear receptor that is activated by farnesol metabolites","volume":"81","author":"Forman","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0765","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.brainres.2008.08.012","article-title":"Reduced sensitivity to diet-induced obesity in mice carrying a mutant 5-HT6 receptor","volume":"1236","author":"Frassetto","year":"2008","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0770","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1152\/physrev.00004.2003","article-title":"Role of endogenous cannabinoids in synaptic signaling","volume":"83","author":"Freund","year":"2003","journal-title":"Physiol Rev"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0775","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1054\/plef.2001.0360","article-title":"Endocannabinoids in the central nervous system \u2014 An overview","volume":"66","author":"Fride","year":"2002","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0780","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.neuropharm.2010.10.006","article-title":"Electrical stimulation of the lateral habenula produces an inhibitory effect on sucrose self-administration","volume":"60","author":"Friedman","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0785","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1073\/pnas.98.4.2005","article-title":"Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice","volume":"98","author":"Fruebis","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0790","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1074\/jbc.M607809200","article-title":"Food intake regulates oleoylethanolamide formation and degradation in the proximal small intestine","volume":"282","author":"Fu","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0795","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nature01921","article-title":"Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha","volume":"425","author":"Fu","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0800","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.neuropharm.2005.02.013","article-title":"Oleoylethanolamide, an endogenous PPAR-alpha agonist, lowers body weight and hyperlipidemia in obese rats","volume":"48","author":"Fu","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0805","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1124\/jpet.108.140210","article-title":"Remogliflozin etabonate, in a novel category of selective low-affinity sodium glucose cotransporter (SGLT2) inhibitors, exhibits antidiabetic efficacy in rodent models","volume":"327","author":"Fujimori","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0810","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/sj.tpj.6500026","article-title":"The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression","volume":"1","author":"Fuke","year":"2001","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0815","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.neuron.2006.09.006","article-title":"Leptin regulation of the mesoaccumbens dopamine pathway","volume":"51","author":"Fulton","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0820","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1517\/14656560902824152","article-title":"Combination pharmaceutical therapies for obesity","volume":"10","author":"Gadde","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0825","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(11)60205-5","article-title":"Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): A randomized, placebo-controlled, phase 3 trial","volume":"377","author":"Gadde","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0830","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1001\/jama.289.14.1820","article-title":"Zonisamide for weight loss in obese adults: A randomized controlled trial","volume":"289","author":"Gadde","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0835","doi-asserted-by":"crossref","first-page":"8096","DOI":"10.1523\/JNEUROSCI.0036-10.2010","article-title":"The fat-induced satiety factor oleoylethanolamide suppresses feeding through central release of oxytocin","volume":"30","author":"Gaetani","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0840","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/sj.npp.1300166","article-title":"Modulation of meal pattern in the rat by the anorexic lipid mediator oleoylethanolamide","volume":"28","author":"Gaetani","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0845","first-page":"124","article-title":"PRX-07034, a potent and selective 5-HT6 receptor antagonist, reduces food intake and body weight in rats","volume":"101","author":"Gannon","year":"2006","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0850","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1124\/mol.104.009092","article-title":"Akt is essential for insulin modulation of amphetamine-induced human dopamine transporter cell-surface redistribution","volume":"68","author":"Garcia","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0855","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1113\/jphysiol.2008.164152","article-title":"Pharmacological targeting of the serotonergic system for the treatment of obesity","volume":"587","author":"Garfield","year":"2009","journal-title":"J Physiol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0860","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3945\/ajcn.111.024927","article-title":"Two-year sustained weight loss and metabolic benefits with controlled-release phentermine\/topiramate in obese and overweight adults (SEQUEL): A randomized, placebo-controlled, phase 3 extension study","volume":"95","author":"Garvey","year":"2012","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"10.1016\/j.pharmthera.2016.10.015_bb0865","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.appet.2008.12.003","article-title":"Preliminary validation of the Yale Food Addiction Scale","volume":"52","author":"Gearhardt","year":"2009","journal-title":"Appetite"},{"issue":"4","key":"10.1016\/j.pharmthera.2016.10.015_bb0870","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.eatbeh.2013.07.002","article-title":"Preliminary validation of the Yale Food Addiction Scale for children","volume":"14","author":"Gearhardt","year":"2013","journal-title":"Eat Behav"},{"issue":"5","key":"10.1016\/j.pharmthera.2016.10.015_bb0875","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/eat.20957","article-title":"An examination of the food addiction construct in obese patients with binge eating disorder","volume":"45","author":"Gearhardt","year":"2012","journal-title":"Int J Eat Disord"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0880","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1096\/fj.08-110759","article-title":"Evidence for defective mesolimbic dopamine exocytosis in obesity-prone rats","volume":"22","author":"Geiger","year":"2008","journal-title":"FASEB J"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0885","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/1074248413501017","article-title":"New and emerging drug molecules against obesity","volume":"19","author":"George","year":"2014","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0890","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1523\/JNEUROSCI.1714-04.2005","article-title":"The hypothalamic neuropeptide melanin-concentrating hormone acts in the nucleus accumbens to modulate feeding behavior and forced-swim performance","volume":"25","author":"Georgescu","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0895","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1038\/sj.npp.1300964","article-title":"The anxiogenic drug yohimbine reinstates palatable food seeking in a rat relapse model: A role of CRF1 receptors","volume":"31","author":"Ghitza","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0900","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1038\/npp.2012.128","article-title":"Inhibition of opioid transmission at the mu-opioid receptor prevents both food seeking and binge-like eating","volume":"37","author":"Giuliano","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0905","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0014-2999(85)90578-3","article-title":"Postsynaptic alpha 2-noradrenergic receptors mediate feeding induced by paraventricular nucleus injection of norepinephrine and clonidine","volume":"115","author":"Goldman","year":"1985","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0910","doi-asserted-by":"crossref","first-page":"9612","DOI":"10.1523\/JNEUROSCI.22-21-09612.2002","article-title":"A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding","volume":"22","author":"Gomez","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0915","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.brainres.2005.11.035","article-title":"Cannabinoid CB2 receptors: immunohistochemical localization in rat brain","volume":"1071","author":"Gong","year":"2006","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0920","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S1388-1981(00)00049-4","article-title":"Progress towards understanding the role of microsomal triglyceride transfer protein in apolipoprotein-B lipoprotein assembly","volume":"1486","author":"Gordon","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0925","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0167-0115(94)90204-6","article-title":"Two molecular forms of peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1\u201336 and PYY 3\u201336","volume":"51","author":"Grandt","year":"1994","journal-title":"Regul Pept"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0930","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/0196-9781(94)90035-3","article-title":"Characterization of two forms of peptide YY, PYY(1\u201336) and PYY(3\u201336), in the rabbit","volume":"15","author":"Grandt","year":"1994","journal-title":"Peptides"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0935","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00006842-199611000-00004","article-title":"The controls of fat intake","volume":"58","author":"Greenberg","year":"1996","journal-title":"Psychosom Med"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0940","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/oby.2008.461","article-title":"Rational design of a combination medication for the treatment of obesity","volume":"17","author":"Greenway","year":"2009","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0945","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.cmet.2012.06.015","article-title":"Hindbrain neurons as an essential hub in the neuroanatomically distributed control of energy balance","volume":"16","author":"Grill","year":"2012","journal-title":"Cell Metab"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0950","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1210\/endo.133.2.8102095","article-title":"Glucagon-like peptide-1-(7-36) amide, oxyntomodulin, and glucagon interact with a common receptor in a somatostatin-secreting cell line","volume":"133","author":"Gros","year":"1993","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0955","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0021-9150(00)80416-5","article-title":"Bay 13\u20139952 (implitapide), an inhibitor of microsomal triglyceride transfer protein (MTP), blocks secretion of Apo-B lipoproteins","volume":"151","author":"Gruetzmann","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0960","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1098-3597(05)80066-3","article-title":"A constellation of complications: The metabolic syndrome","volume":"7","author":"Grundy","year":"2005","journal-title":"Clin Cornerstone"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0965","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1002\/cne.23282","article-title":"Glucagon-like peptide-1 in the rat brain: distribution of expression and functional implication","volume":"521","author":"Gu","year":"2013","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0970","first-page":"525","article-title":"Lorcaserin (Belviq): A selective serotonin 5-HT2C agonist in the treatment of obesity","volume":"38","author":"Gustafson","year":"2013","journal-title":"P T"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0975","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.physbeh.2004.04.019","article-title":"Glucagon-like peptide 1 (GLP-1) and eating","volume":"82","author":"Gutzwiller","year":"2004","journal-title":"Physiol Behav"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0980","doi-asserted-by":"crossref","first-page":"e646","DOI":"10.1038\/tp.2015.140","article-title":"Leptin levels are reduced by intravenous ghrelin administration and correlated with cue-induced alcohol craving","volume":"5","author":"Haass-Koffler","year":"2015","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0985","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/1082","article-title":"Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons","volume":"1","author":"Hahn","year":"1998","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0990","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1126\/science.7624777","article-title":"Weight-reducing effects of the plasma protein encoded by the obese gene","volume":"269","author":"Halaas","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb0995","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/phar.1342","article-title":"Use of prescription antiobesity drugs in the United States","volume":"33","author":"Hampp","year":"2013","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1000","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0896-6273(01)00293-8","article-title":"Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity","volume":"30","author":"Hara","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1005","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.brainres.2007.12.055","article-title":"Autoradiographic analysis of ghrelin receptors in the rat hypothalamus","volume":"1196","author":"Harrold","year":"2008","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.neuropharm.2012.01.007","article-title":"CNS regulation of appetite","volume":"63","author":"Harrold","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1015","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0006-8993(02)03245-6","article-title":"Down-regulation of cannabinoid-1 (CB-1) receptors in specific extrahypothalamic regions of rats with dietary obesity: A role for endogenous cannabinoids in driving appetite for palatable food?","volume":"952","author":"Harrold","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1020","doi-asserted-by":"crossref","first-page":"E1023","DOI":"10.1210\/jc.2011-3432","article-title":"Melanocortin-4 receptor signaling is required for weight loss after gastric bypass surgery","volume":"97","author":"Hatoum","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1025","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1001\/archfami.9.2.160","article-title":"Orlistat in the long-term treatment of obesity in primary care settings","volume":"9","author":"Hauptman","year":"2000","journal-title":"Arch Fam Med"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1030","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0167-0115(01)00358-5","article-title":"Anorectic, thermogenic and anti-obesity activity of a selective orexin-1 receptor antagonist in ob\/ob mice","volume":"104","author":"Haynes","year":"2002","journal-title":"Regul Pept"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1035","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1365-2125.2009.03549.x","article-title":"Regulatory challenges for new drugs to treat obesity and comorbid metabolic disorders","volume":"68","author":"Heal","year":"2009","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1040","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.neuropharm.2012.01.017","article-title":"What is the prognosis for new centrally-acting anti-obesity drugs?","volume":"63","author":"Heal","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1045","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0893-133X(99)00099-8","article-title":"Genotype influences in vivo dopamine transporter availability in human striatum","volume":"22","author":"Heinz","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1050","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/ijo.2013.74","article-title":"Addiction potential of phentermine prescribed during long-term treatment of obesity","volume":"38","author":"Hendricks","year":"2014","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1055","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1046\/j.1460-9568.2000.00008.x","article-title":"The distribution of the mRNA and protein products of the melanin-concentrating hormone (MCH) receptor gene, slc-1, in the central nervous system of the rat","volume":"12","author":"Hervieu","year":"2000","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1060","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0306-4522(01)00033-1","article-title":"Gene expression and protein distribution of the orexin-1 receptor in the rat brain and spinal cord","volume":"103","author":"Hervieu","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1065","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1001\/jama.282.16.1568","article-title":"Recombinant leptin for weight loss in obese and lean adults: A randomized, controlled, dose-escalation trial","volume":"282","author":"Heymsfield","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1070","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1001\/archinte.160.9.1321","article-title":"Effects of weight loss with orlistat on glucose tolerance and progression to type 2 diabetes in obese adults","volume":"160","author":"Heymsfield","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1075","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1016\/S0196-9781(02)00269-3","article-title":"Neuropeptides, food intake and body weight regulation: A hypothalamic focus","volume":"23","author":"Hillebrand","year":"2002","journal-title":"Peptides"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1080","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/dom.12636","article-title":"Therapeutic potential of Takeda-G-protein-receptor-5 (TGR5) agonists. Hope or hype?","volume":"18","author":"Hodge","year":"2016","journal-title":"Diabetes Obes Metab"},{"issue":"Suppl. 3","key":"10.1016\/j.pharmthera.2016.10.015_bb1085","first-page":"35","article-title":"Studies on the antiobesity activity of tetrahydrolipstatin, a potent and selective inhibitor of pancreatic lipase","volume":"11","author":"Hogan","year":"1987","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1090","doi-asserted-by":"crossref","first-page":"784","DOI":"10.2337\/diacare.26.3.784","article-title":"Pramlintide as an adjunct to insulin therapy improves long-term glycemic and weight control in patients with type 2 diabetes: A 1-year randomized controlled trial","volume":"26","author":"Hollander","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1095","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.neuron.2006.08.023","article-title":"Leptin receptor signaling in midbrain dopamine neurons regulates feeding","volume":"51","author":"Hommel","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1100","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1161\/01.ATV.20.6.1595","article-title":"Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients","volume":"20","author":"Hotta","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1105","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1124\/pr.114.009514","article-title":"Serotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorder","volume":"67","author":"Howell","year":"2015","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1110","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1002\/oby.20356","article-title":"Ascending dose-controlled trial of beloranib, a novel obesity treatment for safety, tolerability, and weight loss in obese women","volume":"21","author":"Hughes","year":"2013","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1115","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/MOL.0b013e328312707c","article-title":"New approaches to target microsomal triglyceride transfer protein","volume":"19","author":"Hussain","year":"2008","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1120","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0092-8674(00)81865-6","article-title":"Targeted disruption of the melanocortin-4 receptor results in obesity in mice","volume":"88","author":"Huszar","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1125","first-page":"R577","article-title":"Effects of area postrema\/caudal medial nucleus of solitary tract lesions on food intake and body weight","volume":"244","author":"Hyde","year":"1983","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1130","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1210\/en.2002-221033","article-title":"Hypothalamic proopiomelanocortin neurons are glucose responsive and express K(ATP) channels","volume":"144","author":"Ibrahim","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1135","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.bbalip.2015.05.006","article-title":"Feeding-induced oleoylethanolamide mobilization is disrupted in the gut of diet-induced obese rodents","volume":"1851","author":"Igarashi","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1140","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1124\/jpet.111.180943","article-title":"Regulation of ingestive behaviors in the rat by GSK1521498, a novel micro-opioid receptor-selective inverse agonist","volume":"339","author":"Ignar","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1145","doi-asserted-by":"crossref","first-page":"179674","DOI":"10.1155\/2011\/179674","article-title":"Pharmacotherapies for obesity: Past, current, and future therapies","volume":"2011","author":"Ioannides-Demos","year":"2011","journal-title":"J Obes"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1150","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1476-5381.2009.00183.x","article-title":"Peripheral endocannabinoid dysregulation in obesity: Relation to intestinal motility and energy processing induced by food deprivation and re-feeding","volume":"158","author":"Izzo","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1155","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/mds.870120502","article-title":"The dopamine transporter: A crucial component regulating dopamine transmission","volume":"12","author":"Jaber","year":"1997","journal-title":"Mov Disord"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1160","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1517\/13543784.2014.918952","article-title":"Investigational drugs in Phase II clinical trials for the treatment of obesity: Implications for future development of novel therapies","volume":"23","author":"Jackson","year":"2014","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1165","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/sj.bjp.0704379","article-title":"Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats","volume":"134","author":"Jamshidi","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1170","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1369-1600.2006.00041.x","article-title":"Ghrelin administration into tegmental areas stimulates locomotor activity and increases extracellular concentration of dopamine in the nucleus accumbens","volume":"12","author":"Jerlhag","year":"2007","journal-title":"Addict Biol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1175","doi-asserted-by":"crossref","first-page":"11318","DOI":"10.1073\/pnas.0812809106","article-title":"Requirement of central ghrelin signaling for alcohol reward","volume":"106","author":"Jerlhag","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1180","doi-asserted-by":"crossref","first-page":"E194","DOI":"10.1152\/ajpendo.00149.2004","article-title":"Evidence against a role for insulin-signaling proteins PI 3-kinase and Akt in insulin resistance in human skeletal muscle induced by short-term GH infusion","volume":"288","author":"Jessen","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1185","doi-asserted-by":"crossref","first-page":"10166","DOI":"10.1038\/ncomms10166","article-title":"Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction","volume":"6","author":"Jiang","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1190","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ecl.2006.11.012","article-title":"Management of adult growth hormone deficiency","volume":"36","author":"Johannsson","year":"2007","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1195","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/nn.2519","article-title":"Dopamine D2 receptors in addiction-like reward dysfunction and compulsive eating in obese rats","volume":"13","author":"Johnson","year":"2010","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1200","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/0026-0495(94)90269-0","article-title":"Fuel metabolism, energy expenditure, and thyroid function in growth hormone-treated obese women: A double-blind placebo-controlled study","volume":"43","author":"Jorgensen","year":"1994","journal-title":"Metabolism"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1205","doi-asserted-by":"crossref","first-page":"R773","DOI":"10.1152\/ajpregu.00727.2007","article-title":"Prolonged hyperphagia with high-fat feeding contributes to exacerbated weight gain in rats with adult-onset obesity","volume":"295","author":"Judge","year":"2008","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1210","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.cmet.2012.01.021","article-title":"2-arachidonoylglycerol signaling in forebrain regulates systemic energy metabolism","volume":"15","author":"Jung","year":"2012","journal-title":"Cell Metab"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1215","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1210\/er.2005-0005","article-title":"Adiponectin and adiponectin receptors","volume":"26","author":"Kadowaki","year":"2005","journal-title":"Endocr Rev"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1220","first-page":"68","article-title":"Interacting appetite-regulating pathways in the hypothalamic regulation of body weight","volume":"20","author":"Kalra","year":"1999","journal-title":"Endocr Rev"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1225","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1172\/JCI116972","article-title":"The human kidney low affinity Na+\/glucose cotransporter SGLT2. Delineation of the major renal reabsorptive mechanism for D-glucose","volume":"93","author":"Kanai","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1230","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/j.1463-1326.2010.01242.x","article-title":"Randomized controlled trial to investigate the effects of a newly developed formulation of phentermine diffuse-controlled release for obesity","volume":"12","author":"Kang","year":"2010","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1235","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1210\/en.2011-0174","article-title":"Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4","volume":"152","author":"Kanoski","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1240","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/2050-6511-14-26","article-title":"First human dose-escalation study with remogliflozin etabonate, a selective inhibitor of the sodium-glucose transporter 2 (SGLT2), in healthy subjects and in subjects with type 2 diabetes mellitus","volume":"14","author":"Kapur","year":"2013","journal-title":"BMC Pharmacol Toxicol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1245","doi-asserted-by":"crossref","first-page":"430","DOI":"10.5414\/CNP71430","article-title":"An unusual complication of treatment with orlistat","volume":"71","author":"Karamadoukis","year":"2009","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1250","doi-asserted-by":"crossref","first-page":"9435","DOI":"10.1074\/jbc.M209706200","article-title":"A G protein-coupled receptor responsive to bile acids","volume":"278","author":"Kawamata","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1255","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00213-013-3248-9","article-title":"Hindbrain orexin 1 receptors influence palatable food intake, operant responding for food, and food-conditioned place preference in rats","volume":"231","author":"Kay","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1260","doi-asserted-by":"crossref","first-page":"1875S","DOI":"10.1093\/jn\/127.9.1875S","article-title":"Body weight set-points: determination and adjustment","volume":"127","author":"Keesey","year":"1997","journal-title":"J Nutr"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1265","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.neubiorev.2003.11.015","article-title":"Ventral striatal control of appetitive motivation: Role in ingestive behavior and reward-related learning","volume":"27","author":"Kelley","year":"2004","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1270","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1523\/JNEUROSCI.22-09-03306.2002","article-title":"The neuroscience of natural rewards: Relevance to addictive drugs","volume":"22","author":"Kelley","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1275","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00213-014-3666-3","article-title":"The opioid receptor pharmacology of GSK1521498 compared to other ligands with differential effects on compulsive reward-related behaviours","volume":"232","author":"Kelly","year":"2015","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1280","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1159\/000125597","article-title":"Opioids hyperpolarize beta-endorphin neurons via mu-receptor activation of a potassium conductance","volume":"52","author":"Kelly","year":"1990","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1285","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nrn3105","article-title":"Common cellular and molecular mechanisms in obesity and drug addiction","volume":"12","author":"Kenny","year":"2011","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1290","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1093\/emboj\/19.6.1290","article-title":"BDNF regulates eating behavior and locomotor activity in mice","volume":"19","author":"Kernie","year":"2000","journal-title":"EMBO J"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1295","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1210\/edrv.20.6.0385","article-title":"The glucagon-like peptides","volume":"20","author":"Kieffer","year":"1999","journal-title":"Endocr Rev"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1300","doi-asserted-by":"crossref","first-page":"490","DOI":"10.2337\/db12-0598","article-title":"Chronic treatment with a melanocortin-4 receptor agonist causes weight loss, reduces insulin resistance, and improves cardiovascular function in diet-induced obese rhesus macaques","volume":"62","author":"Kievit","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1305","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/dc06-2375","article-title":"Effects of once-weekly dosing of a long-acting release formulation of exenatide on glucose control and body weight in subjects with type 2 diabetes","volume":"30","author":"Kim","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1310","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/dom.12457","article-title":"Efficacy and safety of beloranib for weight loss in obese adults: A randomized controlled trial","volume":"17","author":"Kim","year":"2015","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1315","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1124\/jpet.110.177527","article-title":"A small-molecule inhibitor of enterocytic microsomal triglyceride transfer protein, SLx-4090: Biochemical, pharmacodynamic, pharmacokinetic, and safety profile","volume":"337","author":"Kim","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1320","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1677\/jme.1.02165","article-title":"Assessment of the anti-obesity effects of the TNP-470 analog, CKD-732","volume":"38","author":"Kim","year":"2007","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1325","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/sj.bjp.0704767","article-title":"Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: Stimulation of eating by 2-arachidonoyl glycerol","volume":"136","author":"Kirkham","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1330","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1210\/jc.2005-2529","article-title":"Activation of dopamine D2 receptors lowers circadian leptin concentrations in obese women","volume":"91","author":"Kok","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1335","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1210\/jc.2002-021545","article-title":"Synthetic exendin-4 (exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes","volume":"88","author":"Kolterman","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1340","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/npp.2009.110","article-title":"Neurocircuitry of addiction","volume":"35","author":"Koob","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1345","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/oby.2009.155","article-title":"Weight loss, HbA1c reduction, and tolerability of cetilistat in a randomized, placebo-controlled phase 2 trial in obese diabetics: Comparison with orlistat (Xenical)","volume":"18","author":"Kopelman","year":"2010","journal-title":"Obesity (Silver Spring)"},{"issue":"Suppl. 1","key":"10.1016\/j.pharmthera.2016.10.015_bb1350","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1530\/eje.0.151S067","article-title":"Ghrelin: update on a novel hormonal system","volume":"151","author":"Korbonits","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1355","doi-asserted-by":"crossref","first-page":"e12004","DOI":"10.14814\/phy2.12004","article-title":"Obesity attenuates D2 autoreceptor-mediated inhibition of putative ventral tegmental area dopaminergic neurons","volume":"2","author":"Koyama","year":"2014","journal-title":"Physiol Rep"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1360","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/509","article-title":"Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans","volume":"19","author":"Krude","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1365","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1001\/archinte.162.22.2557","article-title":"Body mass index and the risk of stroke in men","volume":"162","author":"Kurth","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1370","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1210\/en.2007-1321","article-title":"Serotonin 5-HT2C receptor agonist promotes hypophagia via downstream activation of melanocortin 4 receptors","volume":"149","author":"Lam","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1375","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/nm764","article-title":"Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension","volume":"8","author":"Launay","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1380","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/ajcn\/68.3.591","article-title":"Interaction of insulin, glucagon-like peptide 1, gastric inhibitory polypeptide, and appetite in response to intraduodenal carbohydrate","volume":"68","author":"Lavin","year":"1998","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1385","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1210\/en.2005-0972","article-title":"Attenuated peptide YY release in obese subjects is associated with reduced satiety","volume":"147","author":"le Roux","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1390","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/379632a0","article-title":"Abnormal splicing of the leptin receptor in diabetic mice","volume":"379","author":"Lee","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1395","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1046\/j.1528-1157.2003.27402.x","article-title":"The effects of adjunctive topiramate on cognitive function in patients with epilepsy","volume":"44","author":"Lee","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1400","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1172\/JCI27989","article-title":"Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis","volume":"116","author":"Lefebvre","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1405","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1016\/j.psyneuen.2013.09.005","article-title":"Fasting-induced increase in plasma ghrelin is blunted by intravenous alcohol administration: A within-subject placebo-controlled study","volume":"38","author":"Leggio","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1410","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.biopsych.2014.03.019","article-title":"Intravenous ghrelin administration increases alcohol craving in alcohol-dependent heavy drinkers: A preliminary investigation","volume":"76","author":"Leggio","year":"2014","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1415","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0006-8993(82)90933-7","article-title":"Distribution of alpha-adrenergic, beta-adrenergic and dopaminergic receptors in discrete hypothalamic areas of rat","volume":"233","author":"Leibowitz","year":"1982","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1420","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0091-3057(84)80022-2","article-title":"Chronic norepinephrine injection into the hypothalamic paraventricular nucleus produces hyperphagia and increased body weight in the rat","volume":"21","author":"Leibowitz","year":"1984","journal-title":"Pharmacol Biochem Behav"},{"issue":"Suppl. 1","key":"10.1016\/j.pharmthera.2016.10.015_bb1425","first-page":"S51","article-title":"Hypothalamic serotonin: pharmacological, biochemical, and behavioral analyses of its feeding-suppressive action","volume":"11","author":"Leibowitz","year":"1988","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1430","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cmet.2009.06.011","article-title":"Leptin acts via leptin receptor-expressing lateral hypothalamic neurons to modulate the mesolimbic dopamine system and suppress feeding","volume":"10","author":"Leinninger","year":"2009","journal-title":"Cell Metab"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1435","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.eatbeh.2013.08.008","article-title":"Smoking and alcohol use in gastric bypass patients","volume":"14","author":"Lent","year":"2013","journal-title":"Eat Behav"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1440","doi-asserted-by":"crossref","first-page":"R941","DOI":"10.1152\/ajpregu.00245.2002","article-title":"Reduced central leptin sensitivity in rats with diet-induced obesity","volume":"283","author":"Levin","year":"2002","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1445","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1038\/ncomms3384","article-title":"Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity","volume":"4","author":"Li","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1450","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1172\/JCI111809","article-title":"Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction","volume":"75","author":"Liddle","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1455","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1007\/s00125-009-1402-z","article-title":"Growth hormone improves body composition, fasting blood glucose, glucose tolerance and liver triacylglycerol in a mouse model of diet-induced obesity and type 2 diabetes","volume":"52","author":"List","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1460","first-page":"446","article-title":"Phentermine\/Topiramate extended-release capsules (qsymia) for weight loss","volume":"38","author":"Lonneman","year":"2013","journal-title":"P T"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1465","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/371799a0","article-title":"Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor","volume":"371","author":"Lu","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1470","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3945\/jn.108.097618","article-title":"Homeostatic and hedonic signals interact in the regulation of food intake","volume":"139","author":"Lutter","year":"2009","journal-title":"J Nutr"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1475","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/0031-9384(94)90076-0","article-title":"Reduction of food intake in rats by intraperitoneal injection of low doses of amylin","volume":"55","author":"Lutz","year":"1994","journal-title":"Physiol Behav"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1480","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1371\/journal.pbio.0050143","article-title":"A K ATP channel-dependent pathway within alpha cells regulates glucagon release from both rodent and human islets of Langerhans","volume":"5","author":"MacDonald","year":"2007","journal-title":"PLoS Biol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1485","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.appet.2007.05.004","article-title":"Immediate effects of chocolate on experimentally induced mood states","volume":"49","author":"Macht","year":"2007","journal-title":"Appetite"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1490","doi-asserted-by":"crossref","first-page":"6957","DOI":"10.1073\/pnas.92.15.6957","article-title":"Increased expression in adipocytes of ob RNA in mice with lesions of the hypothalamus and with mutations at the db locus","volume":"92","author":"Maffei","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1495","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1038\/sj.npp.1301376","article-title":"Endocannabinoid hedonic hotspot for sensory pleasure: Anandamide in nucleus accumbens shell enhances \u2018liking\u2019 of a sweet reward","volume":"32","author":"Mahler","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1500","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1749-6632.1980.tb47245.x","article-title":"Biosynthetic studies on ACTH, beta-endorphin, and alpha-melanotropin in the rat","volume":"343","author":"Mains","year":"1980","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1505","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1126\/science.284.5418.1362","article-title":"Identification of a nuclear receptor for bile acids","volume":"284","author":"Makishima","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1510","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.tins.2006.01.008","article-title":"Involvement of the endocannabinoid system in drug addiction","volume":"29","author":"Maldonado","year":"2006","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1515","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.cmet.2008.03.007","article-title":"Ghrelin modulates brain activity in areas that control appetitive behavior","volume":"7","author":"Malik","year":"2008","journal-title":"Cell Metab"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1520","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/cne.903500307","article-title":"Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: An in situ hybridization study","volume":"350","author":"Mansour","year":"1994","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1525","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/cne.1190","article-title":"Differential expression of orexin receptors 1 and 2 in the rat brain","volume":"435","author":"Marcus","year":"2001","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1530","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/nm1561","article-title":"Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells","volume":"13","author":"Maresz","year":"2007","journal-title":"Nat Med"},{"issue":"405","key":"10.1016\/j.pharmthera.2016.10.015_bb1535","first-page":"e401","article-title":"Use of topiramate in pregnancy and risk of oral clefts","volume":"207","author":"Margulis","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1540","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/0091-3057(94)90327-1","article-title":"An appetitively conditioned taste elicits a preferential increase in mesolimbic dopamine release","volume":"48","author":"Mark","year":"1994","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1545","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1079\/PNS19910067","article-title":"Gut hormones in glucose homeostasis","volume":"50","author":"Marks","year":"1991","journal-title":"Proc Nutr Soc"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1550","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0091-3057(80)90048-9","article-title":"Morphine selectively influences macronutrient intake in the rat","volume":"12","author":"Marks-Kaufman","year":"1980","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1555","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/BF00432739","article-title":"Modifications of nutrient selection induced by naloxone in rats","volume":"74","author":"Marks-Kaufman","year":"1981","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1560","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1073\/pnas.052706899","article-title":"Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperactive, and hyperphagic and have altered metabolism","volume":"99","author":"Marsh","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1565","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0091-3057(95)00187-5","article-title":"Mesolimbic dopaminergic system activity as a function of food reward: A microdialysis study","volume":"53","author":"Martel","year":"1996","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1570","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1210\/jc.2010-1848","article-title":"Lorcaserin, a 5-HT(2C) receptor agonist, reduces body weight by decreasing energy intake without influencing energy expenditure","volume":"96","author":"Martin","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1575","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0031-9384(77)90218-9","article-title":"Decreased feeding in rats following hepatic-portal infusion of glucagon","volume":"19","author":"Martin","year":"1977","journal-title":"Physiol Behav"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1580","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S0006-291X(02)02550-0","article-title":"Identification of membrane-type receptor for bile acids (M-BAR)","volume":"298","author":"Maruyama","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1585","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.neuropharm.2010.11.002","article-title":"Region-specific diet-induced and leptin-induced cellular leptin resistance includes the ventral tegmental area in rats","volume":"60","author":"Matheny","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1590","first-page":"R1038","article-title":"Long-term CCK-leptin synergy suggests a role for CCK in the regulation of body weight","volume":"276","author":"Matson","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1595","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2183\/pjab.86.131","article-title":"Establishment of a concept of visceral fat syndrome and discovery of adiponectin","volume":"86","author":"Matsuzawa","year":"2010","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1600","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1124\/pr.55.1.6","article-title":"International Union of Pharmacology. XXXV. The glucagon receptor family","volume":"55","author":"Mayo","year":"2003","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1605","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.biopsych.2006.08.008","article-title":"Topiramate for the treatment of binge eating disorder associated with obesity: A placebo-controlled study","volume":"61","author":"McElroy","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1610","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2165\/00003495-199856020-00007","article-title":"Orlistat","volume":"56","author":"McNeely","year":"1998","journal-title":"Drugs"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1615","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1111\/j.1460-9568.2012.08168.x","article-title":"Insulin in the ventral tegmental area reduces hedonic feeding and suppresses dopamine concentration via increased reuptake","volume":"36","author":"Mebel","year":"2012","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1620","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1523\/JNEUROSCI.4503-03.2004","article-title":"Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors","volume":"24","author":"Melis","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1625","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.neulet.2007.04.012","article-title":"The cannabinoid antagonist SR 141716A (Rimonabant) reduces the increase of extra-cellular dopamine release in the rat nucleus accumbens induced by a novel high palatable food","volume":"419","author":"Melis","year":"2007","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1630","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0006-8993(91)90342-S","article-title":"Insulin and the paraventricular hypothalamus: modulation of energy balance","volume":"555","author":"Menendez","year":"1991","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1635","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/(SICI)1096-9861(19990111)403:2<261::AID-CNE8>3.0.CO;2-5","article-title":"Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system","volume":"403","author":"Merchenthaler","year":"1999","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1640","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1038\/mp.2012.145","article-title":"Neutral antagonism at the cannabinoid 1 receptor: a safer treatment for obesity","volume":"18","author":"Meye","year":"2013","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1645","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/ajcn\/27.11.1341","article-title":"Microbial bile acid transformation","volume":"27","author":"Midtvedt","year":"1974","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1650","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1101\/gad.7.3.454","article-title":"Cloning of the mouse agouti gene predicts a secreted protein ubiquitously expressed in mice carrying the lethal yellow mutation","volume":"7","author":"Miller","year":"1993","journal-title":"Genes Dev"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1655","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0031-9384(90)90314-T","article-title":"Corn oil and mineral oil stimulate sham feeding in rats","volume":"48","author":"Mindell","year":"1990","journal-title":"Physiol Behav"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1660","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1001\/jama.286.10.1195","article-title":"The continuing epidemics of obesity and diabetes in the United States","volume":"286","author":"Mokdad","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1665","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1210\/er.2008-0027","article-title":"Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects","volume":"30","author":"Moller","year":"2009","journal-title":"Endocr Rev"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1670","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.regpep.2004.08.038","article-title":"Identification of ghrelin and its receptor in neurons of the rat arcuate nucleus","volume":"126","author":"Mondal","year":"2005","journal-title":"Regul Pept"},{"issue":"Suppl. 2","key":"10.1016\/j.pharmthera.2016.10.015_bb1675","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1038\/sj.ijo.0802125","article-title":"Pathways from obesity to hypertension: from the perspective of a vicious triangle","volume":"26","author":"Montani","year":"2002","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1680","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1055\/s-0032-1331767","article-title":"Beneficial effects of (pGlu-Gln)-CCK-8 on energy intake and metabolism in high fat fed mice are associated with alterations of hypothalamic gene expression","volume":"45","author":"Montgomery","year":"2013","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1685","first-page":"R46","article-title":"Blockade of type A, not type B, CCK receptors attenuates satiety actions of exogenous and endogenous CCK","volume":"262","author":"Moran","year":"1992","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1690","series-title":"Vegetable Oils in Food Technology: Composition, Properties and Uses","first-page":"273","article-title":"Corn oil","author":"Moreau","year":"2011"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1695","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1753-4887.2007.tb00277.x","article-title":"Neurobiology of nutrition and obesity","volume":"65","author":"Morrison","year":"2007","journal-title":"Nutr Rev"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1700","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1136\/bmj.1.5588.352","article-title":"Comparison of continuous and intermittent anorectic therapy in obesity","volume":"1","author":"Munro","year":"1968","journal-title":"Br Med J"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1705","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1146\/annurev.physiol.70.113006.100707","article-title":"Mechanisms of leptin action and leptin resistance","volume":"70","author":"Myers","year":"2008","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1710","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1210\/jcem-64-5-896","article-title":"Hyperglucagonemia increases resting metabolic rate in man during insulin deficiency","volume":"64","author":"Nair","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1715","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/sj.ijo.0801636","article-title":"Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients","volume":"25","author":"Nam","year":"2001","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1720","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/ijo.2012.178","article-title":"Diet-induced obesity: dopamine transporter function, impulsivity and motivation","volume":"37","author":"Narayanaswami","year":"2013","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1725","first-page":"R910","article-title":"GLP-1 slows solid gastric emptying and inhibits insulin, glucagon, and PYY release in humans","volume":"277","author":"Naslund","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1730","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1177\/0091270011399577","article-title":"Opioid receptor modulation of hedonic taste preference and food intake: a single-dose safety, pharmacokinetic, and pharmacodynamic investigation with GSK1521498, a novel mu-opioid receptor inverse agonist","volume":"52","author":"Nathan","year":"2012","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1735","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1755-5949.2010.00172.x","article-title":"Neuropsychiatric adverse effects of centrally acting antiobesity drugs","volume":"17","author":"Nathan","year":"2011","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1740","author":"National Health and Examination Survey"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1745","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1038\/npp.2013.157","article-title":"Role of CB2 cannabinoid receptors in the rewarding, reinforcing, and physical effects of nicotine","volume":"38","author":"Navarrete","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1750","author":"NCI"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1755","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1210\/jc.2007-2414","article-title":"Growth hormone signaling in vivo in human muscle and adipose tissue: Impact of insulin, substrate background, and growth hormone receptor blockade","volume":"93","author":"Nielsen","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1760","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0140-6736(14)60460-8","article-title":"Global, regional, and national prevalence of overweight and obesity in children and adults during 1980\u20132013: A systematic analysis for the Global Burden of Disease Study 2013","volume":"384","author":"Ng","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1765","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000338163","article-title":"The opioid system and food intake: Homeostatic and hedonic mechanisms","volume":"5","author":"Nogueiras","year":"2012","journal-title":"Obes Facts"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1770","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nn0602-861","article-title":"Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats","volume":"5","author":"Obici","year":"2002","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1775","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.pbb.2007.01.004","article-title":"Nicotine deprivation effect\u2019 in rats with intermittent 23-hour access to intravenous nicotine self-administration","volume":"86","author":"O'Dell","year":"2007","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1780","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/adb.12074","article-title":"Enhanced nicotine self-administration and suppressed dopaminergic systems in a rat model of diabetes","volume":"19","author":"O'Dell","year":"2014","journal-title":"Addict Biol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1785","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0006-8993(83)90865-X","article-title":"Norepinephrine and dopamine levels in hypothalamic nuclei of the genetically obese mouse (ob\/ob)","volume":"273","author":"Oltmans","year":"1983","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1790","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0196-9781(01)00609-X","article-title":"Multiple regulation of peptide YY secretion in the digestive tract","volume":"23","author":"Onaga","year":"2002","journal-title":"Peptides"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1795","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1196\/annals.1369.052","article-title":"Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain","volume":"1074","author":"Onaivi","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1800","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1038\/oby.2012.66","article-title":"Randomized placebo-controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: the BLOOM-DM study","volume":"20","author":"O'Neil","year":"2012","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1805","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.brainres.2010.04.028","article-title":"Modulation of the mesolimbic dopamine system by leptin","volume":"1350","author":"Opland","year":"2010","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1810","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000087925","article-title":"Cocaine- and amphetamine-related transcript is involved in the orexigenic effect of endogenous anandamide","volume":"81","author":"Osei-Hyiaman","year":"2005","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1815","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1172\/JCI200523057","article-title":"Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity","volume":"115","author":"Osei-Hyiaman","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1820","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1172\/JCI34827","article-title":"Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice","volume":"118","author":"Osei-Hyiaman","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1825","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.phrs.2003.12.006","article-title":"Oleoylethanolamide inhibits food intake in free-feeding rats after oral administration","volume":"49","author":"Oveisi","year":"2004","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1830","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0140-6736(07)60033-6","article-title":"Drug treatments for obesity: Orlistat, sibutramine, and rimonabant","volume":"369","author":"Padwal","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1835","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1006\/frne.1999.0186","article-title":"Interconnections between the neuroendocrine hypothalamus and the central autonomic system. Geoffrey Harris Memorial Lecture, Kitakyushu, Japan, October 1998","volume":"20","author":"Palkovits","year":"1999","journal-title":"Front Neuroendocrinol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1840","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.tins.2007.06.004","article-title":"Is dopamine a physiologically relevant mediator of feeding behavior?","volume":"30","author":"Palmiter","year":"2007","journal-title":"Trends Neurosci"},{"issue":"1","key":"10.1016\/j.pharmthera.2016.10.015_bb1845","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neuropharm.2012.02.004","article-title":"Hypothalamic neuropeptides and the regulation of appetite. [Review]","volume":"63","author":"Parker","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1850","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1111\/j.1460-9568.2007.05595.x","article-title":"Decreased motivation to eat in mu-opioid receptor-deficient mice","volume":"25","author":"Papaleo","year":"2007","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1855","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2015-310283","article-title":"Microbiota-induced obesity requires farnesoid X receptor","author":"Parseus","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1860","doi-asserted-by":"crossref","first-page":"11777","DOI":"10.1523\/JNEUROSCI.2329-05.2005","article-title":"Hedonic hot spot in nucleus accumbens shell: where do mu-opioids cause increased hedonic impact of sweetness?","volume":"25","author":"Pecina","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1865","doi-asserted-by":"crossref","first-page":"9395","DOI":"10.1523\/JNEUROSCI.23-28-09395.2003","article-title":"Hyperdopaminergic mutant mice have higher \u201cwanting\u201d but not \u201cliking\u201d for sweet rewards","volume":"23","author":"Pecina","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1870","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/j.neuroimage.2004.08.023","article-title":"Images of desire: Food-craving activation during fMRI","volume":"23","author":"Pelchat","year":"2004","journal-title":"Neuroimage"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1875","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1056\/NEJM196105042641801","article-title":"Depression of food intake induced in healthy subjects by glucagon","volume":"264","author":"Penick","year":"1961","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1880","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1038\/ijo.2015.115","article-title":"The role of bile acids in reducing the metabolic complications of obesity after bariatric surgery: A systematic review","volume":"39","author":"Penney","year":"2015","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1885","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s002219900289","article-title":"A second look at the barriers of the medial basal hypothalamus","volume":"132","author":"Peruzzo","year":"2000","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1890","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/(SICI)1097-4679(199906)55:6<685::AID-JCLP3>3.0.CO;2-Y","article-title":"Psychosocial and pharmacological treatment of eating disorders: a review of research findings","volume":"55","author":"Peterson","year":"1999","journal-title":"J Clin Psychol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1895","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/PSY.0b013e3181651651","article-title":"Overweight and obesity are associated with psychiatric disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions","volume":"70","author":"Petry","year":"2008","journal-title":"Psychosom Med"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1900","doi-asserted-by":"crossref","first-page":"9996","DOI":"10.1523\/JNEUROSCI.18-23-09996.1998","article-title":"Neurons containing hypocretin (orexin) project to multiple neuronal systems","volume":"18","author":"Peyron","year":"1998","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1905","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1038\/npp.2012.48","article-title":"Role of orexin-1 receptor mechanisms on compulsive food consumption in a model of binge eating in female rats","volume":"37","author":"Piccoli","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1910","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.2337\/diacare.23.8.1154","article-title":"Bromocriptine: A novel approach to the treatment of type 2 diabetes","volume":"23","author":"Pijl","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1915","first-page":"672","article-title":"The endocannabinoid system: A drug discovery perspective","volume":"6","author":"Piomelli","year":"2005","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1920","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.tem.2013.03.001","article-title":"A fatty gut feeling","volume":"24","author":"Piomelli","year":"2013","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1925","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/ajcn\/81.4.780","article-title":"Association between dietary factors and plasma adiponectin concentrations in men","volume":"81","author":"Pischon","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1930","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.peptides.2009.05.002","article-title":"Animals models of MCH function and what they can tell us about its role in energy balance","volume":"30","author":"Pissios","year":"2009","journal-title":"Peptides"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1935","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1210\/er.2006-0021","article-title":"Expanding the scales: The multiple roles of MCH in regulating energy balance and other biological functions","volume":"27","author":"Pissios","year":"2006","journal-title":"Endocr Rev"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1940","first-page":"1781","article-title":"Liraglutide in weight management","volume":"373","author":"Pi-Sunyer","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1945","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.molmet.2013.12.001","article-title":"Action and therapeutic potential of oxyntomodulin","volume":"3","author":"Pocai","year":"2014","journal-title":"Mol Metab"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1950","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.2337\/db09-0278","article-title":"Glucagon-like peptide 1\/glucagon receptor dual agonism reverses obesity in mice","volume":"58","author":"Pocai","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1955","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/ncpendmet0889","article-title":"Gastric banding to treat obesity: Band-aid or breakthrough?","volume":"4","author":"Polonsky","year":"2008","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1960","doi-asserted-by":"crossref","first-page":"e83741","DOI":"10.1371\/journal.pone.0083741","article-title":"Roux-en-Y gastric bypass increases intravenous ethanol self-administration in dietary obese rats","volume":"8","author":"Polston","year":"2013","journal-title":"PLoS One"},{"issue":"814-825","key":"10.1016\/j.pharmthera.2016.10.015_bb1965","first-page":"e227","article-title":"Expression and function of the bile acid receptor GpBAR1 (TGR5) in the murine enteric nervous system","volume":"22","author":"Poole","year":"2010","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1970","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1301\/002966402320634797","article-title":"Leptin and insulin action in the central nervous system","volume":"60","author":"Porte","year":"2002","journal-title":"Nutr Rev"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1975","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.2337\/db11-0030","article-title":"Farnesoid X receptor deficiency improves glucose homeostasis in mouse models of obesity","volume":"60","author":"Prawitt","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1980","doi-asserted-by":"crossref","first-page":"11527","DOI":"10.1073\/pnas.1322016111","article-title":"Satiety factor oleoylethanolamide recruits the brain histaminergic system to inhibit food intake","volume":"111","author":"Provensi","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1985","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nm1029","article-title":"Adiponectin acts in the brain to decrease body weight","volume":"10","author":"Qi","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1990","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/380243a0","article-title":"A role for melanin-concentrating hormone in the central regulation of feeding behaviour","volume":"380","author":"Qu","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb1995","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cmet.2010.02.015","article-title":"CB(1) signaling in forebrain and sympathetic neurons is a key determinant of endocannabinoid actions on energy balance","volume":"11","author":"Quarta","year":"2010","journal-title":"Cell Metab"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2000","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/sj.ijo.0802583","article-title":"CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity","volume":"28","author":"Ravinet Trillou","year":"2004","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2005","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1038\/oby.2009.184","article-title":"Enhanced weight loss with pramlintide\/metreleptin: An integrated neurohormonal approach to obesity pharmacotherapy","volume":"17","author":"Ravussin","year":"2009","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1079\/PNS19920004","article-title":"Role of gastrointestinal factors in hunger and satiety in man","volume":"51","author":"Read","year":"1992","journal-title":"Proc Nutr Soc"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2015","first-page":"251","article-title":"The predominant cholecystokinin in human plasma and intestine is cholecystokinin-33","volume":"86","author":"Rehfeld","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2020","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0899-9007(00)00452-4","article-title":"Influence of topiramate in the regulation of energy balance","volume":"16","author":"Richard","year":"2000","journal-title":"Nutrition"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2025","doi-asserted-by":"crossref","first-page":"e0119034","DOI":"10.1371\/journal.pone.0119034","article-title":"Activation of the GLP-1 receptors in the nucleus of the solitary tract reduces food reward behavior and targets the mesolimbic system","volume":"10","author":"Richard","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2030","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00213-008-1136-5","article-title":"Inhibition of orexin-1\/hypocretin-1 receptors inhibits yohimbine-induced reinstatement of ethanol and sucrose seeking in Long-Evans rats","volume":"199","author":"Richards","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2035","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.drugalcdep.2014.03.028","article-title":"Insulin resistant rats display enhanced rewarding effects of nicotine","volume":"140","author":"Richardson","year":"2014","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-0270(95)00153-0","article-title":"Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy","volume":"66","author":"Richardson","year":"1996","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2045","doi-asserted-by":"crossref","first-page":"11070","DOI":"10.1523\/JNEUROSCI.3695-04.2004","article-title":"Independent presynaptic and postsynaptic mechanisms regulate endocannabinoid signaling at multiple synapses in the ventral tegmental area","volume":"24","author":"Riegel","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2050","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1242\/dmm.009621","article-title":"Anti-obesity drugs: past, present and future","volume":"5","author":"Rodgers","year":"2012","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2055","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/35102582","article-title":"An anorexic lipid mediator regulated by feeding","volume":"414","author":"Rodriguez de Fonseca","year":"2001","journal-title":"Nature"},{"issue":"Suppl. 1","key":"10.1016\/j.pharmthera.2016.10.015_bb2060","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0021-9150(99)80144-0","article-title":"Hypolipidemic effects of R103757, a potent stereoselective inhibitor of microsomal triglyceride transfer protein (MTP)","volume":"144","author":"Roevens","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2065","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/ijo.2010.155","article-title":"Taste, olfactory and food texture reward processing in the brain and obesity","volume":"35","author":"Rolls","year":"2011","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2070","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.2337\/dc09-1203","article-title":"Effects of exenatide and lifestyle modification on body weight and glucose tolerance in obese subjects with and without pre-diabetes","volume":"33","author":"Rosenstock","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2075","doi-asserted-by":"crossref","first-page":"4428","DOI":"10.1210\/endo.139.10.6332","article-title":"A C-terminal fragment of Agouti-related protein increases feeding and antagonizes the effect of alpha-melanocyte stimulating hormone in vivo","volume":"139","author":"Rossi","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2080","doi-asserted-by":"crossref","first-page":"7257","DOI":"10.1073\/pnas.0706473105","article-title":"Leptin responsiveness restored by amylin agonism in diet-induced obesity: Evidence from nonclinical and clinical studies","volume":"105","author":"Roth","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2085","doi-asserted-by":"crossref","first-page":"5035","DOI":"10.1210\/endo.142.11.8593","article-title":"Inhibition of central amylin signaling increases food intake and body adiposity in rats","volume":"142","author":"Rushing","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2090","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nrendo.2013.47","article-title":"Emerging combinatorial hormone therapies for the treatment of obesity and T2DM","volume":"9","author":"Sadry","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2095","doi-asserted-by":"crossref","first-page":"8938","DOI":"10.1073\/pnas.132043299","article-title":"Important role of hypothalamic Y2 receptors in body weight regulation revealed in conditional knockout mice","volume":"99","author":"Sainsbury","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2100","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0092-8674(00)80949-6","article-title":"Orexins and orexin receptors: A family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior","volume":"92","author":"Sakurai","year":"1998","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.pharmthera.2016.10.015_bb2105","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.neuropharm.2011.10.008","article-title":"The role of the gut\/brain axis in modulating food intake","volume":"63","author":"Sam","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2110","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00213-004-1877-8","article-title":"Reduced sensitivity to reward in CB1 knockout mice","volume":"176","author":"Sanchis-Segura","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2115","first-page":"145","article-title":"The hungry stomach: physiology, disease, and drug development opportunities","volume":"1","author":"Sanger","year":"2010","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2120","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0896-6273(02)00969-8","article-title":"The need to feed: Homeostatic and hedonic control of eating","volume":"36","author":"Saper","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2125","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1038\/oby.2008.244","article-title":"Evaluation of urinary oxalate levels in patients receiving gastrointestinal lipase inhibitor","volume":"16","author":"Sarica","year":"2008","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2130","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1210\/en.2002-220675","volume":"144","author":"Sarkar","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2135","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.cmet.2013.01.003","article-title":"Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist","volume":"17","author":"Sayin","year":"2013","journal-title":"Cell Metab"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2140","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s00125-005-1763-x","article-title":"Leptin resistance exacerbates diet-induced obesity and is associated with diminished maximal leptin signalling capacity in rats","volume":"48","author":"Scarpace","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2145","doi-asserted-by":"crossref","first-page":"R493","DOI":"10.1152\/ajpregu.90669.2008","article-title":"Leptin resistance: A prediposing factor for diet-induced obesity","volume":"296","author":"Scarpace","year":"2009","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"Suppl. 2","key":"10.1016\/j.pharmthera.2016.10.015_bb2150","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.2337\/dc11-s205","article-title":"Sibutramine on cardiovascular outcome","volume":"34","author":"Scheen","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2155","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/ijo.2009.56","article-title":"Activation in brain energy regulation and reward centers by food cues varies with choice of visual stimulus","volume":"33","author":"Schur","year":"2009","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2160","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cmet.2008.08.005","article-title":"The lipid messenger OEA links dietary fat intake to satiety","volume":"8","author":"Schwartz","year":"2008","journal-title":"Cell Metab"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2165","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/35007534","article-title":"Central nervous system control of food intake","volume":"404","author":"Schwartz","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2170","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1006\/appe.1998.0211","article-title":"Pharmacology of food conditioned preferences","volume":"31","author":"Sclafani","year":"1998","journal-title":"Appetite"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2175","doi-asserted-by":"crossref","first-page":"R983","DOI":"10.1152\/ajpregu.00323.2007","article-title":"The GLP-1 agonist exendin-4 reduces food intake in nonhuman primates through changes in meal size","volume":"293","author":"Scott","year":"2007","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2180","doi-asserted-by":"crossref","first-page":"8263","DOI":"10.1523\/JNEUROSCI.5858-09.2010","article-title":"Regulation of nucleus accumbens activity by the hypothalamic neuropeptide melanin-concentrating hormone","volume":"30","author":"Sears","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2185","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0376-8716(98)00065-9","article-title":"Relapse to drug-seeking: Neural and molecular mechanisms","volume":"51","author":"Self","year":"1998","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2190","first-page":"493","article-title":"Myristoyl-CoA:protein N-myristoyltransferase: A novel molecular approach for cancer therapy (Review)","volume":"10","author":"Selvakumar","year":"2002","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2195","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00213-002-1224-x","article-title":"The reinstatement model of drug relapse: History, methodology and major findings","volume":"168","author":"Shaham","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2200","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.physbeh.2015.05.037","article-title":"Deletion of Melanin Concentrating Hormone Receptor-1 disrupts overeating in the presence of food cues","volume":"152","author":"Sherwood","year":"2015","journal-title":"Physiol Behav"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2205","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1172\/JCI118951","article-title":"Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a","volume":"98","author":"Shimano","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2210","first-page":"134","article-title":"Eating disorders with binge-eating behaviour are associated with the s allele of the 3\u2032-UTR VNTR polymorphism of the dopamine transporter gene","volume":"29","author":"Shinohara","year":"2004","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2215","series-title":"Neuropsychopharmacology: The Fifth Generation of Progress","first-page":"1381","article-title":"Recent advances in animal models of drug addiction and alcoholism","author":"Shippenberg","year":"2002"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2220","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/clpt.2011.20","article-title":"Evaluation of the abuse potential of lorcaserin, a serotonin 2C (5-HT2C) receptor agonist, in recreational polydrug users","volume":"89","author":"Shram","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2225","first-page":"CD007654","article-title":"Long-term effects of weight-reducing drugs in hypertensive patients","author":"Siebenhofer","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2230","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1093\/cercor\/bhi038","article-title":"Pictures of appetizing foods activate gustatory cortices for taste and reward","volume":"15","author":"Simmons","year":"2005","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2235","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0304-3940(97)13479-6","article-title":"A possible role for tyrosine kinases in the regulation of the neuronal dopamine transporter in mouse striatum","volume":"224","author":"Simon","year":"1997","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2240","doi-asserted-by":"crossref","first-page":"6099","DOI":"10.1073\/pnas.94.12.6099","article-title":"The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2","volume":"94","author":"Sin","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2245","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0092-8674(00)00062-3","article-title":"Targeted disruption of the nuclear receptor FXR\/BAR impairs bile acid and lipid homeostasis","volume":"102","author":"Sinal","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2250","series-title":"Presented at the North American association for the study of obesity annual scientific meeting, New Orleans, LA","article-title":"Bupropion and naltrexone interact synergistically to decrease food intake in mice","author":"Sinnayah","year":"2007"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2255","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0140-6736(97)11509-4","article-title":"Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group","volume":"352","author":"Sjostrom","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2260","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3389\/fnins.2013.00181","article-title":"The central GLP-1: implications for food and drug reward","volume":"7","author":"Skibicka","year":"2013","journal-title":"Front Neurosci"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2265","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.neuroscience.2011.02.016","article-title":"Ghrelin directly targets the ventral tegmental area to increase food motivation","volume":"180","author":"Skibicka","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2270","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1369-1600.2010.00294.x","article-title":"Role of ghrelin in food reward: Impact of ghrelin on sucrose self-administration and mesolimbic dopamine and acetylcholine receptor gene expression","volume":"17","author":"Skibicka","year":"2012","journal-title":"Addict Biol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2275","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1210\/en.2011-1606","article-title":"Ghrelin interacts with neuropeptide Y Y1 and opioid receptors to increase food reward","volume":"153","author":"Skibicka","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2280","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.neuropharm.2013.06.004","article-title":"Divergent circuitry underlying food reward and intake effects of ghrelin: dopaminergic VTA-accumbens projection mediates ghrelin's effect on food reward but not food intake","volume":"73","author":"Skibicka","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2285","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/S1053-8119(03)00253-2","article-title":"Feeding-induced dopamine release in dorsal striatum correlates with meal pleasantness ratings in healthy human volunteers","volume":"19","author":"Small","year":"2003","journal-title":"Neuroimage"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2290","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1093\/brain\/124.9.1720","article-title":"Changes in brain activity related to eating chocolate: From pleasure to aversion","volume":"124","author":"Small","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2295","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1161\/CIR.0b013e318235eb4d","article-title":"AHA\/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation","volume":"124","author":"Smith","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2300","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1056\/NEJMoa0909809","article-title":"Multicenter, placebo-controlled trial of lorcaserin for weight management","volume":"363","author":"Smith","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2305","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.tins.2013.05.003","article-title":"Neuronal circuits that regulate feeding behavior and metabolism","volume":"36","author":"Sohn","year":"2013","journal-title":"Trends Neurosci"},{"issue":"4","key":"10.1016\/j.pharmthera.2016.10.015_bb2310","doi-asserted-by":"crossref","first-page":"229","DOI":"10.5483\/BMBRep.2015.48.4.272","article-title":"Network of hypothalamic neurons that control appetite","volume":"48","author":"Sohn","year":"2015","journal-title":"BMB Rep"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2315","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0092-8674(01)00240-9","article-title":"Obesity and the regulation of energy balance","volume":"104","author":"Spiegelman","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2320","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/0196-9781(86)90149-X","article-title":"Neuropeptide Y chronically injected into the hypothalamus: a powerful neurochemical inducer of hyperphagia and obesity","volume":"7","author":"Stanley","year":"1986","journal-title":"Peptides"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2325","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1152\/physrev.00015.2004","article-title":"Hormonal regulation of food intake","volume":"85","author":"Stanley","year":"2005","journal-title":"Physiol Rev"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2330","doi-asserted-by":"crossref","first-page":"810","DOI":"10.3945\/ajcn.2010.29663","article-title":"Oral administration of glucagon-like peptide 1 or peptide YY 3-36 affects food intake in healthy male subjects","volume":"92","author":"Steinert","year":"2010","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2335","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1176\/ajp.148.6.705","article-title":"The serotonin syndrome","volume":"148","author":"Sternbach","year":"1991","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2340","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1037\/a0013600","article-title":"Relation of reward from food intake and anticipated food intake to obesity: A functional magnetic resonance imaging study","volume":"117","author":"Stice","year":"2008","journal-title":"J Abnorm Psychol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2345","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.pneurobio.2005.04.003","article-title":"Mechanisms of neurotransmitter release by amphetamines: A review","volume":"75","author":"Sulzer","year":"2005","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2350","first-page":"35","article-title":"Management of obesity and cardiometabolic risk \u2014 Role of phentermine\/extended release topiramate","volume":"7","author":"Sweeting","year":"2014","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2355","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1046\/j.1460-9568.2002.02041.x","article-title":"Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids","volume":"15","author":"Szabo","year":"2002","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2360","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.2337\/diabetes.54.12.3510","article-title":"Resistance to diet-induced obesity in mu-opioid receptor-deficient mice: Evidence for a \u201cthrifty gene\u201d","volume":"54","author":"Tabarin","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/PL00005896","article-title":"The insulin signaling pathway","volume":"169","author":"Taha","year":"1999","journal-title":"J Membr Biol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2370","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1006\/geno.2002.6771","article-title":"Melanin-concentrating hormone receptor subtypes 1 and 2: Species-specific gene expression","volume":"79","author":"Tan","year":"2002","journal-title":"Genomics"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2375","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2337\/db12-0797","article-title":"Coadministration of glucagon-like peptide-1 during glucagon infusion in humans results in increased energy expenditure and amelioration of hyperglycemia","volume":"62","author":"Tan","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2380","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/0092-8674(95)90151-5","article-title":"Identification and expression cloning of a leptin receptor, OB-R","volume":"83","author":"Tartaglia","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2385","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2147\/DMSO.S36276","article-title":"Lorcaserin for weight management","volume":"6","author":"Taylor","year":"2013","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2390","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.2337\/db07-1623","article-title":"Cannabinoid type 1 receptor blockade promotes mitochondrial biogenesis through endothelial nitric oxide synthase expression in white adipocytes","volume":"57","author":"Tedesco","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2395","doi-asserted-by":"crossref","DOI":"10.2337\/dc15-0772","article-title":"Liraglutide reduces CNS activation in response to visual food cues only after short-term treatment in patients with type 2 diabetes","author":"Ten Kulve","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2400","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1172\/JCI25811","article-title":"Ghrelin action in the brain controls adipocyte metabolism","volume":"116","author":"Theander-Carrillo","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2405","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2009.08.001","article-title":"TGR5-mediated bile acid sensing controls glucose homeostasis","volume":"10","author":"Thomas","year":"2009","journal-title":"Cell Metab"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2410","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1093\/ajcn\/69.6.1135","article-title":"Differential effects of saturated and monounsaturated fatty acids on postprandial lipemia and incretin responses in healthy subjects","volume":"69","author":"Thomsen","year":"1999","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2415","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2337\/diacare.27.1.155","article-title":"XENical in the prevention of diabetes in obese subjects (XENDOS) study: A randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients","volume":"27","author":"Torgerson","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2420","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.nut.2007.08.008","article-title":"Relationship between stress, eating behavior, and obesity","volume":"23","author":"Torres","year":"2007","journal-title":"Nutrition"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2425","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0014-5793(98)01266-6","article-title":"Distribution of orexin receptor mRNA in the rat brain","volume":"438","author":"Trivedi","year":"1998","journal-title":"FEBS Lett"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2430","doi-asserted-by":"crossref","first-page":"30817","DOI":"10.1074\/jbc.M402367200","article-title":"Insulin\/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity","volume":"279","author":"Tsuchida","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2435","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1210\/jcem-72-1-51","article-title":"Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man","volume":"72","author":"Veldhuis","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2440","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0196-9781(99)00022-4","article-title":"Corticotropin-releasing factor (CRF) induced anorexia is not influenced by a melanocortin 4 receptor blockage","volume":"20","author":"Vergoni","year":"1999","journal-title":"Peptides"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2445","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/ijo.2012.35","article-title":"Anti-obesity effects of the combined administration of CB1 receptor antagonist rimonabant and melanin-concentrating hormone antagonist SNAP-94847 in diet-induced obese mice","volume":"37","author":"Verty","year":"2013","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2450","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1176\/ajp.2007.164.5.708","article-title":"Issues for DSM-V: Should obesity be included as a brain disorder?","volume":"164","author":"Volkow","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2455","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/syn.10075","article-title":"Nonhedonic\u201d food motivation in humans involves dopamine in the dorsal striatum and methylphenidate amplifies this effect","volume":"44","author":"Volkow","year":"2002","journal-title":"Synapse"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2460","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1098\/rstb.2008.0107","article-title":"Overlapping neuronal circuits in addiction and obesity: Evidence of systems pathology","volume":"363","author":"Volkow","year":"2008","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2465","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/7854_2011_169","article-title":"Food and drug reward: Overlapping circuits in human obesity and addiction","volume":"11","author":"Volkow","year":"2012","journal-title":"Curr Top Behav Neurosci"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2470","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/oby.2008.469","article-title":"Inverse association between BMI and prefrontal metabolic activity in healthy adults","volume":"17","author":"Volkow","year":"2009","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2475","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/nn1452","article-title":"How can drug addiction help us understand obesity?","volume":"8","author":"Volkow","year":"2005","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2480","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.psyneuen.2009.09.005","article-title":"Orexin and leptin are associated with nicotine craving: A link between smoking, appetite and reward","volume":"35","author":"von der Goltz","year":"2010","journal-title":"Psychoneuroendocrinology"},{"issue":"913-916","key":"10.1016\/j.pharmthera.2016.10.015_bb2485","article-title":"Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome","volume":"143","author":"Vrieze","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2490","doi-asserted-by":"crossref","first-page":"R1003","DOI":"10.1152\/ajpregu.00011.2007","article-title":"Brain-derived neurotrophic factor in the hypothalamic paraventricular nucleus reduces energy intake","volume":"293","author":"Wang","year":"2007","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2495","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/ijo.2013.145","article-title":"Effect of combined naltrexone and bupropion therapy on the brain's reactivity to food cues","volume":"38","author":"Wang","year":"2014","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2500","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1517\/14728222.6.5.601","article-title":"The role of dopamine in motivation for food in humans: Implications for obesity","volume":"6","author":"Wang","year":"2002","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2505","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0140-6736(00)03643-6","article-title":"Brain dopamine and obesity","volume":"357","author":"Wang","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2510","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1111\/j.1460-9568.2006.04674.x","article-title":"Mu-opioid receptor cellular function in the nucleus accumbens is essential for hedonically driven eating","volume":"23","author":"Ward","year":"2006","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2515","first-page":"R30","article-title":"Determinants of high-fat diet hyperphagia: Experimental dissection of orosensory and postingestive effects","volume":"269","author":"Warwick","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2520","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJM199809103391103","article-title":"An assessment of heart-valve abnormalities in obese patients taking dexfenfluramine, sustained-release dexfenfluramine, or placebo. Sustained-Release Dexfenfluramine Study Group","volume":"339","author":"Weissman","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2525","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0899-9007(00)00415-9","article-title":"Norepinephrine and the control of food intake","volume":"16","author":"Wellman","year":"2000","journal-title":"Nutrition"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2530","doi-asserted-by":"crossref","first-page":"724","DOI":"10.2337\/diacare.25.4.724","article-title":"A randomized study and open-label extension evaluating the long-term efficacy of pramlintide as an adjunct to insulin therapy in type 1 diabetes","volume":"25","author":"Whitehouse","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2535","author":"WHO"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2540","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1159\/000054491","article-title":"Co-localization of growth hormone secretagogue receptor and NPY mRNA in the arcuate nucleus of the rat","volume":"70","author":"Willesen","year":"1999","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2545","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.physbeh.2014.03.013","article-title":"Neural integration of satiation and food reward: Role of GLP-1 and orexin pathways","volume":"136","author":"Williams","year":"2014","journal-title":"Physiol Behav"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2550","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1056\/NEJM198411293112203","article-title":"Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction","volume":"311","author":"Williams","year":"1984","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.pharmthera.2016.10.015_bb2555","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/nn.3217","article-title":"From neuroanatomy to behavior: Central integration of peripheral signals regulating feeding behavior","volume":"15","author":"Williams","year":"2012","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2560","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2337\/diab.38.3.321","article-title":"Increased neuropeptide Y concentrations in specific hypothalamic regions of streptozocin-induced diabetic rats","volume":"38","author":"Williams","year":"1989","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2565","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1146\/annurev.neuro.24.1.429","article-title":"To eat or to sleep? Orexin in the regulation of feeding and wakefulness","volume":"24","author":"Willie","year":"2001","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2570","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/cne.21383","article-title":"Distribution of type 1 cannabinoid receptor (CB1)-immunoreactive axons in the mouse hypothalamus","volume":"503","author":"Wittmann","year":"2007","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2575","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1037\/h0035927","article-title":"Metabolic hormones and regulation of body weight","volume":"81","author":"Woods","year":"1974","journal-title":"Psychol Rev"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2580","doi-asserted-by":"crossref","first-page":"795","DOI":"10.2174\/1381612033455323","article-title":"Insulin and the blood\u2013brain barrier","volume":"9","author":"Woods","year":"2003","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2585","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.neuroscience.2005.06.009","article-title":"Peripheral nerve injury induces cannabinoid receptor 2 protein expression in rat sensory neurons","volume":"135","author":"Wotherspoon","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2590","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1210\/endo.141.11.7873","article-title":"The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion","volume":"141","author":"Wren","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2595","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.2337\/diabetes.54.8.2390","article-title":"Subcutaneous oxyntomodulin reduces body weight in overweight and obese subjects: A double-blind, randomized, controlled trial","volume":"54","author":"Wynne","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2600","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1677\/joe.1.05866","article-title":"Appetite control","volume":"184","author":"Wynne","year":"2005","journal-title":"J Endocrinol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2605","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nn1073","article-title":"Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor","volume":"6","author":"Xu","year":"2003","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2610","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nature01705","article-title":"Cloning of adiponectin receptors that mediate antidiabetic metabolic effects","volume":"423","author":"Yamauchi","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2615","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1210\/jcem.86.8.7741","article-title":"Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin","volume":"86","author":"Yang","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2620","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1001\/jama.2013.281361","article-title":"Long-term drug treatment for obesity: A systematic and clinical review","volume":"311","author":"Yanovski","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2625","doi-asserted-by":"crossref","first-page":"10379","DOI":"10.1073\/pnas.0511313103","article-title":"Targeted gene disruption of methionine aminopeptidase 2 results in an embryonic gastrulation defect and endothelial cell growth arrest","volume":"103","author":"Yeh","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2630","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/2404","article-title":"A frameshift mutation in MC4R associated with dominantly inherited human obesity","volume":"20","author":"Yeo","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2635","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1460-9568.2004.03095.x","article-title":"Lesions of dorsolateral striatum preserve outcome expectancy but disrupt habit formation in instrumental learning","volume":"19","author":"Yin","year":"2004","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2640","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ejphar.2006.06.069","article-title":"The mu-opioid receptor subtype is required for the anorectic effect of an opioid receptor antagonist","volume":"545","author":"Zhang","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2645","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1037\/0735-7044.117.2.202","article-title":"Nucleus accumbens opioid, GABAergic, and dopaminergic modulation of palatable food motivation: contrasting effects revealed by a progressive ratio study in the rat","volume":"117","author":"Zhang","year":"2003","journal-title":"Behav Neurosci"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2650","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S0022-3565(24)37432-4","article-title":"Intake of high-fat food is selectively enhanced by mu opioid receptor stimulation within the nucleus accumbens","volume":"285","author":"Zhang","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2655","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/372425a0","article-title":"Positional cloning of the mouse obese gene and its human homologue","volume":"372","author":"Zhang","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2660","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/cne.20515","article-title":"Orexin-A projections to the caudal medulla and orexin-induced c-Fos expression, food intake, and autonomic function","volume":"485","author":"Zheng","year":"2005","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2665","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1177\/009127009603601104","article-title":"Metabolic profiles of minimally absorbed orlistat in obese\/overweight volunteers","volume":"36","author":"Zhi","year":"1996","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.10.015_bb2670","doi-asserted-by":"crossref","first-page":"13226","DOI":"10.1073\/pnas.0605376103","article-title":"Vaccination against weight gain","volume":"103","author":"Zorrilla","year":"2006","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725816301942?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725816301942?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T18:53:55Z","timestamp":1749668035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725816301942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":534,"alternative-id":["S0163725816301942"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2016.10.015","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Obesity: Current and potential pharmacotherapeutics and targets","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2016.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}